Genbody said Thursday that it will launch "GenBody COVID-19 Ag," a rapid antigen diagnostic test kit for Covid-19, in the global market after receiving export approval from the Ministry of Food and Drug Safety.
|Genbody received export approval for GenBody COVID-19 Ag from the Ministry of Food and Drug Safety on Thursday.|
With the latest export approval, the company can ship two Covid-19 diagnostic kits. GenBody COVID-19 Ag has recently won EU's Conformite Europeenne (CE) certification and the company is registering the product in each country.
The latest Covid-19 testing kit can detect the virus in the early stage of Covid-19, which will contribute to a swift prevention of the viral spread, the company said.
The diagnostic kit produces results within 15 minutes after the hospital takes a sample from the patient's nasal or throat with a cotton swab.
A shortened testing time, simple instructions and its affordable price will meet the high demand in countries with weak medical infrastructure, the company added.
Genbody CTO Chong Chom-kyu vowed to do his best to ensure the smooth export of developed products through additional overseas certification and product registration by country.
<© Korea Biomedical Review, All rights reserved.>